Patents by Inventor F. Michael Hudson

F. Michael Hudson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20180002298
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: April 27, 2017
    Publication date: January 4, 2018
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20170022174
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: May 10, 2016
    Publication date: January 26, 2017
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 9334251
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: May 10, 2016
    Assignee: PROTAMED, INC.
    Inventors: Luke A Esposito, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D Snow
  • Compounds for the treatment of Neurodegenerative Diseases
    Publication number: 20150274681
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.
    Type: Application
    Filed: June 16, 2015
    Publication date: October 1, 2015
    Applicant: PROTEOTECH INC.
    Inventors: LUKE A. ESPOSITO, MARISA C. YADON, JOEL CUMMINGS, F. MICHAEL HUDSON, THOMAS LAKE, QUBAI HU, JUDY CAM, ALAN D. SNOW
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 9085549
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: July 21, 2015
    Assignee: PROTEOTECH INC
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Compounds for the treatment of neurodegenerative diseases
    Publication number: 20150011604
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 8, 2015
    Applicant: ProteoTech Inc.
    Inventors: Esposito A Luke, Marisa C Yadon, Joel Cummings, F Michael Hudson, Thomas Lake, Qubai Hu, Judy Cam, Alan D. Snow
  • Compounds, compositions, and methods for the treatment of ?-amyloid diseases and synucleinopathies
    Patent number: 8916598
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: December 23, 2014
    Assignee: Proteotech Inc
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow
  • Compounds for the treatment of neurodegenerative diseases
    Patent number: 8865754
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: October 21, 2014
    Assignee: Proteotech Inc.
    Inventors: Luke A. Esposito, Marisa C. Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Franz F. Hefti, Geoffrey Golding, Seok-Rye Choi, Ximin Li, Alan D. Snow, Qubai Hu, Judy Cam
  • Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
    Patent number: 8829198
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of ?-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: September 9, 2014
    Assignee: Proteotech Inc
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow, Lesley Larsen
  • COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20130338202
    Abstract: Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.
    Type: Application
    Filed: March 1, 2012
    Publication date: December 19, 2013
    Applicant: PROTEO TECH, INC
    Inventors: Luke A. Esposito, Marisa C. Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Franz F. Hefti, Geoffrey Golding, Seok-Rye Choi, Ximin Li, Alan D. Snow, Qubai Hu, Judy Cam
  • Compounds, compositions, and methods for the treatment of ?-amyloid diseases and synucleinopathies
    Patent number: 8592476
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of ?-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: November 26, 2013
    Assignee: ProteoTech, Inc.
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan Snow, Lesley Larsen
  • COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES
    Publication number: 20120252858
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of ?-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: April 26, 2012
    Publication date: October 4, 2012
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow, Lesley Larsen
  • Compounds for Use in the Detection of Neurodegenerative Diseases
    Publication number: 20120251448
    Abstract: Provided are the use of the disclosed compounds as imaging agents and methods for in vivo imaging and detection of pathological characteristics unique to synuclein diseases, such as Parkinson's disease.
    Type: Application
    Filed: March 2, 2012
    Publication date: October 4, 2012
    Inventors: Franz F. Hefti, Geoffrey Golding, Ximin Li, Seok-Rye Choi, Luke Esposito, Marisa-Claire Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Alan D. Snow
  • Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
    Publication number: 20120035230
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: August 11, 2011
    Publication date: February 9, 2012
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan D. Snow
  • Compounds, compositions, and methods for the treatment of synucleinopathies
    Patent number: 7919530
    Abstract: Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: April 5, 2011
    Assignee: Proteotech, Inc.
    Inventors: Luke A. Esposito, Joel Cummings, F. Michael Hudson, Alan D. Snow
  • Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
    Publication number: 20100331380
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of ?-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: June 29, 2009
    Publication date: December 30, 2010
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan Snow, Lesley Larsen
  • Compounds, Compositions, and Methods for the Treatment of Synucleinopathies
    Publication number: 20100179223
    Abstract: Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: July 10, 2009
    Publication date: July 15, 2010
    Inventors: Luke A. Esposito, Joel Cummings, F. Michael Hudson, Alan D. Snow
  • Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
    Publication number: 20090111863
    Abstract: Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of ?-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 30, 2009
    Inventors: Luke A. Esposito, F. Michael Hudson, Thomas Lake, Joel Cummings, Manfred Weigele, Alan Snow, Lesley Larsen